CONMED Corp Files 8-K on Operations, Personnel Changes
Ticker: CNMD · Form: 8-K · Filed: Oct 30, 2024 · CIK: 816956
Sentiment: neutral
Topics: operations, personnel-changes, financial-reporting
Related Tickers: CNMD
TL;DR
CONMED filed an 8-K detailing financial results and executive changes. Keep an eye on their next earnings call.
AI Summary
CONMED Corporation filed an 8-K on October 30, 2024, reporting on its results of operations and financial condition. The filing also disclosed the departure of directors or certain officers, the election of directors, the appointment of certain officers, and details on compensatory arrangements for certain officers. Additionally, it included financial statements and exhibits.
Why It Matters
This filing provides crucial updates on CONMED's financial performance and significant changes in its leadership and compensation structures, which can impact investor confidence and future strategic direction.
Risk Assessment
Risk Level: medium — The filing covers financial results and executive changes, which can introduce uncertainty and affect stock performance.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 11311 Concept Blvd Largo, FL 33773 (address) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The 8-K indicates that it reports on 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
Who are the officers or directors whose departure or appointment is being reported?
The filing states that it covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not name the individuals involved in the provided text.
What are the details of the compensatory arrangements for certain officers?
The 8-K mentions 'Compensatory Arrangements of Certain Officers' but does not provide specific details on these arrangements in the text.
When was this 8-K report filed?
This 8-K report was filed on October 30, 2024.
What is CONMED Corporation's principal executive office address?
CONMED Corporation's principal executive office is located at 11311 Concept Blvd, Largo, FL 33773.
Filing Stats: 1,988 words · 8 min read · ~7 pages · Grade level 11.1 · Accepted 2024-10-30 16:09:02
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by ch
- $850,000 — ges: Mr. Beyer will be paid salary of $850,000 per annum ("Base Salary"), which will b
- $5,000,000 — grant date target fair market value of $5,000,000 and comprise 50% performance stock unit
- $1,936,000 — consulting fee equal to the sum of (i) $1,936,000 plus (ii) two (2) times the average of
Filing Documents
- d905685d8k.htm (8-K) — 39KB
- d905685dex101.htm (EX-10.1) — 225KB
- d905685dex102.htm (EX-10.2) — 79KB
- d905685dex991.htm (EX-99.1) — 272KB
- g905685g1030110438140.jpg (GRAPHIC) — 4KB
- g905685g1030110506356.jpg (GRAPHIC) — 3KB
- 0001193125-24-247545.txt ( ) — 826KB
- cnmd-20241030.xsd (EX-101.SCH) — 3KB
- cnmd-20241030_lab.xml (EX-101.LAB) — 17KB
- cnmd-20241030_pre.xml (EX-101.PRE) — 11KB
- d905685d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Index Exhibit No. Description of Exhibit 10.1 Amendment Number 2 to Service Agreement, by and between CONMED U.K. Limited and Pat Beyer, dated October 30, 2024. 10.2 Letter Agreement, by and between CONMED and Curt R. Hartman, dated October 30, 2024. 99.1 Press Release dated October 30, 2024, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance & Chief Financial Officer Date: October 30, 2024